Tracked express · Dispatch before 2pm AEST. Single vials and 10-vial kits in stock

Tracked express · Dispatch before 2pm AEST · Single vials and 10-vial kits in stock

PT-141 (10mg)

Bremelanotide / melanocortin agonist | Research grade | Lyophilised powder

PT-141 (10mg)

PT-141 for melanocortin pathway research

PT-141 (bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist studied in sexual-function and related CNS pathway literature. The Protocol supplies PT-141 as a lyophilised powder for controlled laboratory research.

This catalogue listing is for research inventory only. It is not offered as a medicine, consumer, or cosmetic product.

For laboratory research purposes only. Not for human consumption. Not a medicine, supplement, or cosmetic. Intended for controlled laboratory and in vitro use only.

Request COA

What it's for

PT-141 is a melanocortin receptor agonist (notably MC3R / MC4R pathways). Laboratory and literature interest has focused on:

  • Female hypoactive sexual desire disorder pathway research (approved clinical brand lineage: Vyleesi in some markets)
  • Male erectile function and sexual-desire models via melanocortin CNS signalling
  • Comparative melanocortin work alongside related analogues (e.g. Melanotan II lineage)
  • Appetite and energy-balance exploratory models via central melanocortin receptors
  • Receptor pharmacology and PK/PD characterisation in research settings

Specifications

Stock codeP41
Cap colourRed
SynonymsBremelanotide, PT141
CAS number189691-06-3 (confirm on batch COA)
Chemical formulaC50H68N14O10 (typical literature value)
Molecular weightApprox. 1025.2 g/mol (as per batch COA)
FormWhite to off-white lyophilised powder
Purity≥99.0% (COA validated)
SolubilitySoluble in sterile research solvents as per lab protocol
Quality checksRP-HPLC identity/purity assessment; third-party verification where listed
Net content10mg per vial

Storage and handling

  • Store dry at 2–8°C unless your batch documentation states otherwise.
  • Protect from moisture, light, and repeated temperature cycling.
  • Reconstitute only under trained laboratory procedures using suitable sterile solvents.
  • Follow your organisation’s SOPs for labelling, use, and disposal.

Laboratory mixing overview

Calculate

Vial dilution lab-math

Acknowledgement required

Confirm the research-use acknowledgement to unlock controls and calculate.

Open full calculator

What is included

  • 1 × PT-141, 10mg lyophilised vial
  • Protective inner packing
  • Access to batch-specific COA where available
  • Australia Post tracking after dispatch

Quality signals

  • ≥99% purity target with COA support
  • Third-party laboratory verification on listed batches
  • Tamper-evident packing checks before dispatch
  • Clear product labelling for research inventory control

Product FAQ

Is this lab tested?+

Listed batches are assessed for purity and identity, with Certificates of Analysis available on request for verified lots.

How fast is Australian delivery?+

Express Australia Post typically runs 1 to 3 business days after dispatch, depending on destination.

Is outer packaging discreet?+

Yes. Outer cartons use plain labelling without product descriptors.

What is PT-141 supplied for?+

Research inventory only. It is not for human or veterinary use, therapeutic procedures, or consumer applications.

This product and its description are intended solely for laboratory and controlled research use. Nothing on this page is medical advice, dosing guidance, or an invitation for personal use. Not for human consumption. See also the Research Use Disclaimer. For research purposes only. Not for human consumption. Not a medicine, supplement, or cosmetic. Laboratory and in vitro use only.